Total bufogenin nano cubic liquid crystal and preparation method thereof
A technology of nano-cubic liquid crystal and total bufanolactone, which can be used in pharmaceutical formulations, medical preparations without active ingredients, and medical preparations containing active ingredients, etc. Low, short half-life and other problems, to achieve the effect of improving bioavailability, improving solubility, and large drug loading
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0036] Embodiment 1 Preparation of total bufolide nano-cubic liquid crystals
[0037] Precisely weigh 6mg of total bufolide and 26.1mg of glyceryl monooleate, dissolve in 5ml of absolute ethanol, and form an oil phase in a 60°C water bath; dissolve 3.9mg of poloxamer 407 in 39mL of water, and heat in a water bath same temperature. Slowly and uniformly inject the oil phase into the stirred water phase with a 1mL syringe, and continue to stir for 3h. After the organic solvent is completely volatilized, the primary emulsion is slowly poured into 75 mg of ice water (ice bath) under stirring conditions, and the stirring is continued for 2 hours to obtain total bufolide nanocubic liquid crystals.
[0038] Detection: the average particle diameter of total bufolide nanocubic liquid crystal nanoparticles is 108.4nm, and the encapsulation efficiency is 88.8%.
Embodiment 2
[0039] Example 2 Preparation of total bufolide nano-cubic liquid crystals
[0040] Precisely weigh 6mg of total bufolide and 26.1mg of phosphoglycerides, dissolve in 5ml of absolute ethanol, and form the oil phase in a 60°C water bath; dissolve 3.9mg of poloxamer 407 in 39mL of water, and heat the water bath to the same level as the oil phase temperature. Slowly and uniformly inject the oil phase into the stirred water phase with a 1mL syringe, and continue to stir for 3h. After the organic solvent is completely volatilized, the primary emulsion is slowly poured into 75 mg of ice water (ice bath) under stirring conditions, and the stirring is continued for 2 hours to obtain total bufolide nanocubic liquid crystals.
[0041] Detection: the average particle diameter of total bufolide nanocubic liquid crystal nanoparticles is 138.4nm, and the encapsulation efficiency is 82.5%.
Embodiment 3
[0042] Example 3 Preparation of total bufolide nano-cubic liquid crystals
[0043] Precisely weigh 6mg of total bufolide and 26.1mg of phosphatidylethanolamine, dissolve in 5ml of absolute ethanol, and form an oil phase in a 60°C water bath; dissolve 3.9mg of poloxamer 407 in 39mL of water, and heat in a water bath until it is the same as the oil phase temperature. Slowly and uniformly inject the oil phase into the stirred water phase with a 1mL syringe, and continue to stir for 3h. After the organic solvent is completely volatilized, the primary emulsion is slowly poured into 75 mg of ice water (ice bath) under stirring conditions, and the stirring is continued for 0.5 h to obtain total bufolide nanocubic liquid crystals.
[0044] Detection: the average particle size of total bufolide nanocubic liquid crystal nanoparticles is 135.5nm, and the encapsulation efficiency is 82.0%.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com